Ad is loading...
PASG
Price
$0.52
Change
-$0.07 (-11.86%)
Updated
Nov 15 closing price
102 days until earnings call
SNPX
Price
$2.40
Change
-$0.21 (-8.05%)
Updated
Nov 15 closing price
Ad is loading...

PASG vs SNPX

Header iconPASG vs SNPX Comparison
Open Charts PASG vs SNPXBanner chart's image
Passage Bio
Price$0.52
Change-$0.07 (-11.86%)
Volume$575.97K
CapitalizationN/A
Synaptogenix
Price$2.40
Change-$0.21 (-8.05%)
Volume$22.49K
CapitalizationN/A
PASG vs SNPX Comparison Chart
Loading...
PASG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
PASG vs. SNPX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PASG is a Sell and SNPX is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (PASG: $0.52 vs. SNPX: $2.40)
Brand notoriety: PASG and SNPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PASG: 239% vs. SNPX: 85%
Market capitalization -- PASG: $32.06M vs. SNPX: $3.25M
PASG [@Biotechnology] is valued at $32.06M. SNPX’s [@Biotechnology] market capitalization is $3.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PASG’s FA Score shows that 1 FA rating(s) are green whileSNPX’s FA Score has 1 green FA rating(s).

  • PASG’s FA Score: 1 green, 4 red.
  • SNPX’s FA Score: 1 green, 4 red.
According to our system of comparison, both PASG and SNPX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PASG’s TA Score shows that 4 TA indicator(s) are bullish while SNPX’s TA Score has 4 bullish TA indicator(s).

  • PASG’s TA Score: 4 bullish, 4 bearish.
  • SNPX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both PASG and SNPX are a good buy in the short-term.

Price Growth

PASG (@Biotechnology) experienced а -15.33% price change this week, while SNPX (@Biotechnology) price change was -18.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

PASG is expected to report earnings on Feb 27, 2025.

SNPX is expected to report earnings on May 29, 2024.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PASG($32.1M) has a higher market cap than SNPX($3.25M). PASG YTD gains are higher at: -48.614 vs. SNPX (-64.693). SNPX has higher annual earnings (EBITDA): -6.83M vs. PASG (-73.35M). PASG has more cash in the bank: 91.8M vs. SNPX (27.4M). PASG (0) and SNPX (0) have equivalent revenues.
PASGSNPXPASG / SNPX
Capitalization32.1M3.25M987%
EBITDA-73.35M-6.83M1,074%
Gain YTD-48.614-64.69375%
P/E RatioN/A0.23-
Revenue00-
Total Cash91.8M27.4M335%
Total Debt26.2MN/A-
TECHNICAL ANALYSIS
Technical Analysis
PASGSNPX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 18 days ago
89%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
N/A
View a ticker or compare two or three
Ad is loading...
PASG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNAX0.930.04
+4.57%
Stryve Foods
AIZ218.823.34
+1.55%
Assurant
UPST68.360.97
+1.45%
Upstart Holdings
QSI0.73-0.04
-5.77%
Quantum-Si
THRD12.15-0.75
-5.81%
Third Harmonic Bio

PASG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PASG has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PASG jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PASG
1D Price
Change %
PASG100%
-12.06%
AXON - PASG
43%
Loosely correlated
-0.86%
CYTK - PASG
38%
Loosely correlated
-8.19%
ARRY - PASG
35%
Loosely correlated
-10.22%
CMPX - PASG
33%
Poorly correlated
-13.21%
SNPX - PASG
32%
Poorly correlated
-8.05%
More

SNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNPX has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNPX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPX
1D Price
Change %
SNPX100%
-8.05%
NCNA - SNPX
92%
Closely correlated
-3.87%
RNAC - SNPX
91%
Closely correlated
+1.82%
AGEN - SNPX
91%
Closely correlated
-1.81%
ALLR - SNPX
87%
Closely correlated
-6.38%
NRXP - SNPX
84%
Closely correlated
+2.59%
More